Company & Sponsor Intelligence
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting1
Completed6
Countries1
Therapeutic footprint
autismdepressionepilepsy
Indexed studies
NCT06019182MEHMO Natural History and Biomarkers
epilepsy · United StatesRECRUITING
epilepsy · United StatesRECRUITING
NCT01059201Exome Sequencing in Autistic Spectrum Disorder
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT00999778Optimizing Social and Communication Outcomes for Toddlers With Autism
autism · United StatesNA
autism · United StatesNA
NCT00065962Secretin for the Treatment of Autism
autism · United StatesPHASE3
autism · United StatesPHASE3
NCT00597948Healthy Lifestyles for People With Intellectual Disabilities
autism · United StatesNA
autism · United StatesNA
NCT00965068Cholesterol in ASD: Characterization and Treatment
autism · United StatesPHASE1, PHASE2
autism · United StatesPHASE1, PHASE2
NCT00044174Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants
depression · United StatesCOMPLETED
depression · United StatesCOMPLETED
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →